This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Patterson Cos. (PDCO) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 8.00% and -2.87%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Patterson Companies (PDCO) in Q1 Earnings?
by Zacks Equity Research
Patterson Companies (PDCO) expects Dental and Animal Health arms to boost first-quarter fiscal 2020 results.
Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Patterson Cos. (PDCO) Down 17.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Falling Earnings Estimates Signal Weakness Ahead for Patterson Companies (PDCO)
by Zacks Equity Research
Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Patterson Companies' (PDCO) Earnings Miss Estimates in Q4
by Zacks Equity Research
Patterson Companies' (PDCO) Q4 results benefit from higher revenues, gross margin expansion and solid show by Animal Health segment.
Patterson Cos. (PDCO) Lags Q4 Earnings Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -7.50% and 0.57%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
by Zacks Equity Research
Patterson Companies (PDCO) expects to gain from the Animal Health unit in fourth-quarter fiscal 2019.
Patterson Cos. (PDCO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Patterson Cos. (PDCO) Down 3.1% Since Last Earnings Report?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Patterson Companies (PDCO) Stock
by Zacks Equity Research
A diversified product portfolio and strong Dental business prospects provide Patterson Companies (PDCO) a competitive edge in the MedTech space.
Patterson Companies (PDCO) Earnings Match Estimates in Q3
by Zacks Equity Research
Patterson Companies (PDCO) gains from solid segmental contributions in Q3.
Earnings Preview: Patterson Cos. (PDCO) Q3 Earnings Expected to Decline
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Near-Term Outlook for Dental Supplies Industry Looks Bright
by Zacks Equity Research
The wave of digital transformation is shaping the future of dental supply companies.
Here's Why Investors Should Hold Patterson Companies Stock
by Zacks Equity Research
Patterson Companies (PDCO) gains from solid foothold in theAnimals Health business. However, the company is facing headwinds in the Dental segment.
Why Is Patterson Cos. (PDCO) Down 11% Since Last Earnings Report?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Patterson Companies (PDCO) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Patterson Companies (PDCO) stock is a good choice for value-oriented investors right now from multiple angles.
Patterson Companies (PDCO) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Patterson Companies (PDCO) continues to gain from its Animal Health unit in fiscal Q2.
Patterson Cos. (PDCO) Q2 Earnings Beat Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 8.33% and -0.01%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Pick Patterson Companies (PDCO) Stock?
by Zacks Equity Research
Let's see if Patterson Companies, Inc. (PDCO) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Patterson Cos. (PDCO) Q2 Earnings Expected to Decline
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal Q2 earnings likely to be marred by a soft Dental unit; Animal Health looks promising.
BioLife (BLFS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
BioLife (BLFS) is likely to gain from solid segmental revenues in Q3.
What's in the Offing for DaVita (DVA) This Earnings Season?
by Zacks Equity Research
DaVita (DVA) likely to gain from its Kidney Care wing. However, DaVita RX and GranuFlo units are likely to disappoint.